Shared genetic risk factors for psychiatric illness by Sen, S.
Editorial comment
Shared genetic risk factors for psychiatric
illness
Developments in genomic and statistical technolo-
gies have dramatically advanced our understand-
ing of the role of genes in complex traits, including
psychiatric disorders. Much of the focus has been
on the identiﬁcation of speciﬁc variants involved in
disease, with more than 12 000 genome-wide sig-
niﬁcant associations reported in the past few years.
Beyond associations between genetic variants and
individual phenotypes, one of the most important
interesting outcomes of the genomic revolution has
been a striking recognition that the genes associ-
ated with one phenotype are often associated with
additional phenotypes. For example, 44% of vari-
ants associated with one autoimmune disease are
also associated with a second autoimmune disease
(1). Relevant to psychiatric disorders, a recent Nat-
ure Genetics article from the Psychiatric Genomics
Consortium (PGC) found evidence of substantial
(20–40%) genetic overlap between schizophrenia
(SZ), bipolar disorder (BD), major depression and
attention-deﬁcit hyperactivity disorder (2).
The article by Tesli and colleagues in this issue of
the Acta Psychiatrica Scandinavica builds on this
work to provide more granular understanding of
the genetic relationship between psychosis spectrum
disorders, through the construction of polygenic
risk scores (3). Risk scores are built from the set of
genetic risk alleles associated with a trait in genome-
wide association studies (GWAS), weighted by the
eﬀect size of each risk allele. These scores can help
us to identify the existence and extent of genotypic
overlap between phenotypes. In the current study,
Tesli and colleagues combined variants with an
association P < 0.05 in the large PGC sample
analyses to build SZ and BD risk scores. They then
utilized independent patient samples to assess the
predictive value of these risk scores in distinguish-
ing patients across the full spectrum of psychotic
diagnoses from control subjects. The authors ﬁnd
that both SZ and BD risk scores were associated
with diagnoses across the psychosis spectrum, with
the SZ risk score more strongly associated with
schizophrenia, psychosis NOS, and schizoaﬀective
disorder, and the BD risk score more strongly
associated with bipolar I, bipolar II and bipolar
disorder NOS. While these ﬁndings are not surpris-
ing, they provide further evidence of shared genes
between psychiatric disorders and further evidence
that psychotic disorders should be viewed on a
continuum rather as diagnostically distinct entities.
Much work remains to be done to identify the
speciﬁc genes shared between diagnoses and to
understand the function of these genes. However,
this line of work provides a preview of how genetic
advances could one day help us to develop diagno-
ses with greater biological validity and possibly,
greater clinical utility.
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